Biocryst Pharmaceuticals (BCRX) Times Interest Earned (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Times Interest Earned came in at -$9.88 in Q1 2026, down 1193.55% YoY from $0.9 in Q1 2025, and down 153.64% on a QoQ basis from $18.42 in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Times Interest Earned (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Times Interest Earned data on file, last reported at -$9.88 in Q1 2026.
- Quarterly Times Interest Earned fell 1193.55% year-over-year to -$9.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.38 (down 1680.55% YoY) and the FY2025 annual result came in at $0.9, up 15912.93% from the prior year.
- Times Interest Earned fell to -$9.88 in Q1 2026, from $18.42 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $18.42 in Q4 2025 to a low of -$9.88 in Q1 2026.
- A 5-year average of $0.18 and a median of -$0.47 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2025 — Times Interest Earned jumped 10090.73% — and 2026, when it slumped 1193.55%.
- Tracing BCRX's Times Interest Earned over 5 years: stood at -$1.75 in 2022, then surged by 73.24% to -$0.47 in 2023, then surged by 60.64% to -$0.18 in 2024, then soared by 10090.73% to $18.42 in 2025, then tumbled by 153.64% to -$9.88 in 2026.
- The last three Times Interest Earned figures came in at -$9.88 (Q1 2026), $18.42 (Q4 2025), and $1.02 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 4.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 |
| Mar 31, 2026 | -9.88 |
| Dec 31, 2025 | 18.42 |
| Sep 30, 2025 | 1.02 |
| Jun 30, 2025 | 1.38 |
| Mar 31, 2025 | 0.90 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | 0.31 |
| Jun 30, 2024 | 0.35 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.44 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -1.04 |
| Dec 31, 2022 | -1.75 |
| Sep 30, 2022 | -0.70 |
| Jun 30, 2022 | -1.45 |
| Mar 31, 2022 | -2.10 |
| Dec 31, 2021 | -2.78 |
| Sep 30, 2021 | -3.16 |